Lung cancer is a major public health problem and a leading cause of cancer-related deaths
worldwide. Despite advances in treatment options, the five-year survival rate for lung cancer …

Recent advances in RNA sequencing technologies helped uncover what was once
uncharted territory in the human genome—the complex and versatile world of long …

Expression of the long non-coding RNA (lncRNA) keratin-7 antisense (KRT7-AS) is
downregulated in various types of cancer; however, the impact of KRT7-AS deficiency on …

Long noncoding RNAs (lncRNAs) possess the potential for therapeutic targeting to treat
many disorders, including cancers. Several RNA-based therapeutics (ASOs and small …

Chronic obstructive pulmonary disease (COPD) and lung cancer represent formidable
challenges in global health, characterized by intricate pathophysiological mechanisms and …

Long non-coding RNAs (lncRNAs) are involved in the control of critical tumor-suppressor
and oncogenic pathways in cancer. These types of non-coding RNAs could affect both …

Cancer has become a significant socioeconomic burden globally, with millions of new cases
and deaths each year. The promising field of bioengineering has recently undergone …

Background/aim: Despite great progress in complex gene regulatory mechanisms in the
dynamic tumor microenvironment, the potential contribution of long noncoding RNAs …

Sequencing human genome brought new dimensions to molecular mechanism of
biochemical processes since just a small portion of the genome is translated into protein but …

Endoplasmic reticulum (ER) stress, which ensues from an overwhelming protein folding
capacity, activates the unfolded protein response (UPR) in an effort to restore cellular …